文献速递血栓与止血

COVID-19 与非 COVID-19 患者肺栓塞临床及影像学特征描述:一项 24 个月视角的多中心横断面研究

Description of the clinical and radiological characteristics of pulmonary embolism in COVID-19 vs non-COVID-19 patients: a multicentric cross-sectional study over a 24-month perspective.
PubMed 文献 · J Thromb Haemost · 2025-01-10

该多中心横断面研究纳入 2019 年 2 月 21 日至 2021 年 2 月 20 日连续诊断的 771 例急性肺栓塞患者,其中 89 例 COVID-19 阳性。COVID-19 阳性患者传统静脉血栓栓塞症危险因素更少,肌钙蛋白 T 和 pro-B 型利钠肽水平更低,Qanadli 指数更低,远端栓塞更多,右心室扩张较少。作者认为 COVID-19 患者的肺栓塞可能反映原位血栓炎症过程而非经典栓塞,但该假说需其他研究证实。

要点

  • COVID-19 阳性肺栓塞患者男性占 59.6%,高于阴性患者的 41.5%(P=.001)。
  • COVID-19 阳性患者既往静脉血栓栓塞症 3.5% vs 阴性 11.5%(P=.02),活动性癌症 4.7% vs 24.2%(P<.0001)。
  • COVID-19 阳性患者 Qanadli 指数中位数 4 vs 阴性 7(P=.0013),远端栓塞 53.5% vs 32.9%(P<.001)。

核心结论

  • COVID-19 患者传统静脉血栓栓塞症危险因素较少,可能提示原位血栓炎症过程的作用。
  • COVID-19 患者肺栓塞影像学范围和严重程度较低,可能反映原位血栓炎症过程而非经典栓塞,但该假说需其他研究证实。

研究设计与样本

  • 观察性、多中心、横断面研究,纳入 2019 年 2 月 21 日至 2021 年 2 月 20 日入院时或住院期间连续诊断的肺栓塞患者。
  • 共纳入 771 例急性肺栓塞患者,其中 89 例 COVID-19 阳性。
  • 比较 COVID-19 阳性与阴性患者的临床、实验室数据和计算机断层扫描图像,肺栓塞范围采用 Qanadli 指数评估。

主要发现

  • COVID-19 阳性患者男性占 59.6%,阴性患者占 41.5%(P=.001)。
  • COVID-19 阳性患者既往静脉血栓栓塞症占 3.5%,阴性患者占 11.5%(P=.02);活动性癌症占 4.7% vs 24.2%(P<.0001)。
  • COVID-19 阳性患者肌钙蛋白 T 中位数 10 vs 阴性 32 ng/L(P=.0002),pro-B 型利钠肽中位数 383 vs 1448 pg/mL(P=.004)。
  • COVID-19 阳性患者 Qanadli 指数中位数 4 vs 阴性 7(P=.0013)。
  • COVID-19 阳性患者远端肺栓塞梗阻占 53.5% vs 阴性 32.9%(P<.001),右心室扩张占 4.1% vs 10.9%(P=.09)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出 COVID-19 患者肺栓塞可能反映原位血栓炎症过程而非经典栓塞的假说需其他研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COVID-19 is associated with intense systemic inflammation and abnormal coagulation profile, leading to an increased incidence of pulmonary embolism (PE). OBJECTIVES: This study investigates whether PE in COVID-19 patients has different clinical, laboratory, and radiological characteristics compared with traditional PE in COVID-19-negative patients. METHODS: We conducted an observational, multicentric, cross-sectional study on consecutive patients diagnosed with PE at admission or during hospital stay from February 21, 2019, to February 20, 2021. We compared clinical and laboratory data and computed tomography images between COVID-19-positive and COVID-19-negative patients. The extent of PE was evaluated using the Qanadli Index. RESULTS: Among 771 enrolled patients with acute PE, 89 were COVID-19-positive. COVID-19 patients were predominantly male (59.6% vs 41.5%, P = .001) and exhibited fewer classic venous thromboembolism (VTE) risk factors, such as previous VTE (3.5% vs 11.5%, P = .02) and active cancer (4.7% vs 24.2%, P < .0001). Additionally, these patients showed lower median troponin T and pro-B-type-natriuretic-peptide levels (10 vs 32 ng/L, P = .0002; and 383 vs 1448 pg/mL, P = .004, respectively), a lower median Qanadli Index (4 vs 7, P = .0013), more distal PE obstructions (53.5% vs 32.9%, P < .001), and less frequent right ventricular dilatation (4.1% vs 10.9%, P = .09). CONCLUSION: In COVID-19 patients, traditional VTE risk factors were less frequent, a possible role for in situ thrombo-inflammatory processes. The reduced radiological extent and severity of PE observed in COVID-19 patients may reflect an in situ thrombo-inflammatory process rather than classical embolization; however, this hypothesis needs to be confirmed by other studies.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Sterpone P, Donadini MP, Abatangelo I, et al. Description of the clinical and radiological characteristics of pulmonary embolism in COVID-19 vs non-COVID-19 patients: a multicentric cross-sectional study over a 24-month perspective. J Thromb Haemost. 2025. PMID: 39800258. doi:10.1016/j.jtha.2024.12.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。